As the experimental Covid-19 vaccine being developed by Moderna Therapeutics has begun advancing through studies, it has found an advocate: trial volunteer Ian Haydon, a 29-year-old in Seattle, STAT News reports.
In the 45-person Moderna study, four participants experienced what are known as "Grade 3" adverse events — side effects that are severe or medically significant but not immediately life-threatening.
Haydon, a communications manager at a university, initially found out about the study, which was being run in Seattle, from a colleague who sent him a link. He, along with thousands of other people, applied. They called him 11 days after he applied. Haydon said he was slightly nervous before the second dose. He knew that second doses were given to increase the immune system's response, and wondered if he might have more side effects. His arm became sore much more quickly this time. He got home from the clinic at about noon. At around 10 p.m., he started to get chills. He's normally too hot at night, but he bundled up in sweats. His fingertips felt cold. He fell asleep, but woke up a few hours later with a raging fever.
He and his girlfriend arrived home at 7 a.m., and he slept until noon. His temperature was 101.5. He got up to go to the bathroom, and became so nauseous he threw up. On his way back from the bathroom, he fainted. His girlfriend caught him and kept his head from hitting the floor.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax begins human trials with potential Covid-19 vaccine in AustraliaNovavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness.
Read more »
NCI COVID-19 in Cancer Patients Study (NCCAPS)Attention: theNCI’s COVID-19 in Cancer Patients Study (NCCAPS) is recruiting people with cancer and COVID19, who are receiving cancer treatment, to better understand how both affect treatment and outcomes. Learn more about enrolling:
Read more »
Novavax Coronavirus Vaccine Begins Human TestingNovavax started the first human study of its experimental coronavirus vaccine, making it one of at least 10 shots now being tested in people globally for Covid-19
Read more »
Trump says he's finished hydroxychloroquine regimen to ward off COVID-19The FDA has cautioned against the use of hydroxychloroquine and chloroquine for COVID-19 treatment outside of hospitals or clinical trials.
Read more »
As coronavirus deaths near 100,000, Trump makes America exceptional in all the wrong ways'Trump has transformed America well beyond COVID-19 and the economy. He's eviscerated transparency, accountability, accuracy and competence, for a start,' writes usatodayopinion editor JillDLawrence.
Read more »